Skip to content

Trial to Evaluate the Impact of a Pharmacy-Based Headache Consultation Program on Pharmacists' Knowledge, Attitude, and Confidence

Impact of a Pharmacy-Based Headache Consultation Program on Pharmacists' Knowledge, Attitude and Confidence: Pre-Post Trial - HELP Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058220
Enrollment
40
Registered
2025-07-15
Start date
2025-07-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache

Interventions

A pre-intervention online training session will be conducted to provide pharmacists with knowledge about headaches and instructions on how to use the original Headache Consultation Tool. After complet

Sponsors

Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pharmacists who are currently working in community pharmacies.

Exclusion criteria

Exclusion criteria: 1)Pharmacists who did not provide informed consent. 2)Pharmacists who were scheduled to take maternity leave, childcare leave, or other extended leave during the study period. 3)Pharmacists who were expected to leave their current pharmacy during the study period.

Design outcomes

Primary

MeasureTime frame
Change in pharmacists' knowledge, attitude and confidence about headache from pre-training to 4 weeks after the start of the intervention.

Secondary

MeasureTime frame
1.Change in pharmacists' knowledge, attitude and confidence about headache from pre-training to immediately post-training 2.Change in pharmacists' knowledge, attitude and confidence about headache from immediately post-training to 4 weeks after the start of intervention 3.Proportion of pharmacists continuing to use the headache consultation tool at 12 weeks after the start of the intervention 4.Cumulative number of each educational material distributed by the end of the intervention

Countries

Japan

Contacts

Public ContactKoyu Ishihara

School of Pharmaceutical Sciences, Wakayama Medical University Department of Social & Community Pharmacy

p2230009@wakayama-med.ac.jp073-488-3147

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026